Introduction
In a groundbreaking initiative, Kokoromil Inc., headquartered in Shinjuku, Tokyo, has teamed up with Miyake Town in Nara Prefecture to enhance community health management. The program aims to improve awareness of health risks and facilitate early detection of heart diseases, particularly in an area noted for its higher-than-average cardiac mortality rates compared to the region at large.
The Pilot Program
The program, dubbed the "Heart Disease Care Mind Enhancement Program," was conducted as a pilot study in 2025 with expansive potential benefits for the working-age population. Utilizing Kokoromil’s state-of-the-art home-based 24-hour electrocardiogram testing, titled "Home Heart Dock pro," this initiative successfully visualized risks that traditional health screenings might overlook.
Key Findings
During this pilot study, 80 volunteers from Miyake Town participated, with nearly half (47.5%) being 40 years or younger. This diverse demographic highlights the program's focus on the working generation. Early data revealed alarming results:
1.
Arrhythmias Detected: Approximately 40% (32 individuals) showed some form of arrhythmia. This signifies a significant leap from traditional short-duration tests that often miss transient abnormalities, showcasing the effectiveness of Kokoromil's extended monitoring technology.
2.
Medical Referrals: Out of the identified 40%, 9% (7 persons) were classified as needing immediate medical attention (C rating). These individuals were promptly connected with local healthcare services, demonstrating a proactive approach not found in typical screenings.
3.
Sleep Apnea Indicators: 5% (4 individuals) presented signs of sleep apnea (B rating), validating the study's comprehensive risk assessment in line with existing statistics.
4.
Stress Levels: An alarming 58% of participants experienced high stress, underscoring the urgent need for mental health support in today's fast-paced society.
Project Overview
The cooperative program reached out to all residents of Miyake Town, leveraging Kokoromil’s innovative technology to provide high-precision monitoring without the need for hospital visits. The initiative particularly targeted demographics that may often go undetected in routine health checks, including child-rearing households and employed individuals.
- - Implementation Period: April 2025 - February 2026
- - Participants: 80 residents of Miyake Town
- - Assessment Focus: Detecting arrhythmias, sleep apnea (SAS) symptoms, and stress levels through prolonged monitoring.
Future Initiatives
Based on the success of this pilot study, Kokoromil plans to enhance its outreach and service offerings in the coming year. Key initiatives include:
- - Enhanced Convenience: Introduction of a new device that eliminates the need for an iPhone, providing an easier testing experience.
- - Targeting Younger Demographics: Expanding outreach through events aimed at children and the wider community, encouraging more working-age adults to engage with the initiative.
- - Meeting Diverse Needs: Addressing not just arrhythmias but also increasing awareness about sleep disorders and stress management to cover a broader spectrum of health monitoring.
About Home Heart Dock Pro
Kokoromil’s "Home Heart Dock pro" is designed for at-home, long-duration ECG testing. Users attach a compact ECG device to their chest, allowing data collection for over nine hours. A trained clinical technician then analyzes the data, delivering comprehensive reports that reveal hidden cardiovascular risks. This innovative approach not only detects complex health concerns but also monitors sleep quality and stress, providing a holistic view of an individual's health.
Thanks to an online clinic feature, patients can consult with physicians from home and obtain referrals to hospitals if necessary. The service is particularly popular among middle-aged individuals managing busy lives, as well as those in remote areas with limited access to healthcare facilities.
Company's Mission
Kokoromil aims to create a society where no one regrets not addressing their health, aspiring to eliminate sudden cardiac deaths worldwide. The “Home Heart Dock” service and other health-related projects focus on early detection of conditions often overlooked, with the goal of saving lives and improving overall quality of life for families nationwide.
For more information, visit the
Home Heart Dock Pro sales page.
Company Information
- - Company Name: Kokoromil Inc.
- - CEO: Daiki Hayashi
- - Location: 2F Kanou Building, 6-2-16 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023
- - Established: November 2021
- - Business Focus: Healthcare and clinical research, providing the Home Heart Dock service for non-invasive cardiac risk assessment and monitoring.